查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611217

人类胚胎干细胞市场规模、份额、趋势分析报告：按应用、地区、细分市场预测，2025-2030

Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

人类胚胎干细胞市场成长与趋势

Grand View Research, Inc.最新报告显示，预计到2030年，全球人类胚胎干细胞市场规模将达到40亿美元，2025年至2030年复合年增长率为10.44%。 hESCs 技术由于其宿主-移植物组织相容性高，往往可用于人体组织工程。

发育潜力的维持，即所有三个生殖细胞层对衍生物的贡献，是这些细胞的重要特征。即使克隆诱导和长期未分化扩增后，这种能力仍能持续维持，从而促进摄取。

此外，这些细胞能够表现高水平的碱性磷酸酶（一种关键转录因子）和端粒酶。已发现这些因素对于维持细胞内的多功能至关重要。

此外，hESCs可以轻易地分化为神经元、神经细胞、少突胶质细胞和星状细胞。上述特征对于研究神经发生早期发生的事件序列很有用。

然而，使用来自可行胚胎的干细胞充满了伦理问题，因此科学家正在探索其他方法来创建ESC。其他方法包括诱导胚胎生殖细胞、来自死亡胚胎的干细胞以及其他技术。

人类胚胎干细胞市场报告亮点

  • 到2024年，再生医学将以54.18%的份额占据市场主导地位。再生医学在治疗多种疾病方面取得了重大进展。此外，源自人类胚胎的多功能细胞已成为生物医学研究的焦点。
  • 干细胞生物学研究领域预计将在预测期内表现出最高的复合年增长率。过去，多家生物製药公司已经探索了干细胞生物学的潜力。
  • 在强大的研究基础设施机构和设施的支持下，北美的人类胚胎干细胞将在 2024 年占据市场主导地位。慢性病和遗传疾病的增加对基因治疗产生了巨大的需求。
  • 亚太地区人类胚胎干细胞市场预计在预测期内将显着成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 工业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章 人类胚胎干细胞市场：应用商业分析

  • 细分仪表板
  • 全球人类胚胎干细胞市场应用变化分析
  • 2018-2030年全球人类胚胎干细胞市场规模及趋势分析（依应用）
  • 再生医学
  • 干细胞生物学研究
  • 组织工程
  • 毒性试验

第五章 人类胚胎干细胞市场：区域估算与趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测与趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲人类胚胎干细胞市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲人类胚胎干细胞市场，2018-2030年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争状况

  • 参与企业
  • 策略规划
  • 2024 年企业市场分析
  • 参与企业概况
    • Thermo Fisher Scientific, Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Sartorius AG
    • PromoCell GmBH
    • Takara Bio
    • Lonza
    • Cellartis AB
    • ATCC
    • AcceGen
    • Cell Applications, Inc.
    • Bio-techne
Product Code: GVR-1-68038-394-2

Human Embryonic Stem Cells Market Growth & Trends:

The global human embryonic stem cells market size is expected to reach USD 4.00 billion by 2030, registering to grow at a CAGR of 10.44% from 2025 to 2030 according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Human Embryonic Stem Cells Market Report Highlights:

  • Regenerative medicines dominated the market with a share of 54.18% in 2024. Regenerative medicines offer significant advancements in treating several diseases. Moreover, pluripotent cells originating from human embryos have been central to biomedical research.
  • The stem cell biology research segment will witness the highest CAGR over the forecast period. Several biopharmaceutical companies have explored the potency of stem cell biology in the past.
  • North America human embryonic stem cells dominated the market in 2024 owing to robust research infrastructure institutions and facilities. The rise in chronic diseases and genetic disorders has created a huge demand for gene therapies.
  • Asia Pacific human embryonic stem cell market is anticipated to witness significant growth in the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Application
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Embryonic Stem Cells Market: Application Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Human Embryonic Stem Cells Market Application Movement Analysis
  • 4.3. Global Human Embryonic Stem Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Regenerative Medicine
    • 4.4.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Stem Cell Biology Research
    • 4.5.1. Global Stem Cell Biology Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Tissue Engineering
    • 4.6.1. Global Tissue Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Toxicology Testing
    • 4.7.1. Global Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis by Application

  • 5.1. Regional Dashboard
  • 5.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. North America Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Scenario
      • 5.3.4.4. Mexico Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Denmark
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Denmark Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.8. Sweden
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Sweden Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Norway Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Japan Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. China
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. China Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. South Korea Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Australia
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Australia Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. Thailand Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Scenario
      • 5.6.2.4. Brazil Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Scenario
      • 5.6.3.4. Argentina Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Scenario
      • 5.7.2.4. South Africa Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Scenario
      • 5.7.3.4. Saudi Arabia Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Scenario
      • 5.7.4.4. UAE Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Scenario
      • 5.7.5.4. Kuwait Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Position Analysis, 2024
  • 6.4. Participant's Overview
    • 6.4.1. Thermo Fisher Scientific, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. STEMCELL Technologies
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Merck KGaA
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Sartorius AG
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. PromoCell GmBH
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Takara Bio
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Lonza
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Cellartis AB
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. ATCC
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. AcceGen
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Cell Applications, Inc.
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. Bio-techne
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Human Embryonic Stem Cells Market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 14 France Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 17 Denmark Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Sweden Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 19 Norway Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Japan Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 23 China Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 24 India Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 25 South Korea Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 26 Australia Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 27 Thailand Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 28 LATAM Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 29 LATAM Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Brazil Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 32 MEA Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 33 MEA Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 38 Participant's overview
  • Table 39 Financial performance
  • Table 40 Key companies undergoing expansions
  • Table 41 Key Companies Undergoing Acquisitions
  • Table 42 Key Companies Undergoing Collaborations
  • Table 43 Key companies launching new products
  • Table 44 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Human Embryonic Stem Cells Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Human Embryonic Stem Cells Market Driver Analysis
  • Fig. 12 Human Embryonic Stem Cells Market Restraint Analysis
  • Fig. 13 Human Embryonic Stem Cells Market: Porter's analysis
  • Fig. 14 Human Embryonic Stem Cells Market: PESTEL analysis
  • Fig. 15 Human Embryonic Stem Cells Market: Application outlook and key takeaways
  • Fig. 16 Human Embryonic Stem Cells Market: Application market share analysis, 2023 - 2030
  • Fig. 17 Global regenerative medicine market, 2018 - 2030 (USD Million)
  • Fig. 18 Global stem cell biology research market, 2018 - 2030 (USD Million)
  • Fig. 19 Global tissue engineering market, 2018 - 2030 (USD Million)
  • Fig. 20 Global toxicology testing market, 2018 - 2030 (USD Million)
  • Fig. 21 Regional marketplace: Key takeaways
  • Fig. 22 North America Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Canada Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • Fig. 26 Europe Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 UK Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Germany Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Spain Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Italy Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 France Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Denmark Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Sweden Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Norway Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Asia-Pacific Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Japan Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 China Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 India Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 South Korea Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Australia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Thailand Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 LATAM Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Brazil Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Argentina Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 MEA Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Saudi Arabia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 South Africa Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 UAE Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Kuwait Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Key company categorization
  • Fig. 52 Company market positioning
  • Fig. 53 Market Participant categorization
  • Fig. 54 Strategy framework